PharmiWeb.com - Global Pharma News & Resources

Pharmacy - Events

The Pharma and Biotech Patent Litigation Track at the Patent Litigation Europe Summit 2026 is the leading European forum for life sciences IP counsel and litigators to benchmark enforcement strategies, navigate evolving UPC case law, and prepare for the next wave of biosimilar and generic challenges. Taking place on 20–21 January 2026 at the Beurs van Berlage in Amsterdam, the track continues the legacy of the Pharma and Biotech Patent Litigation Summit while introducing a broader cross-sector environment under the newly rebranded Patent Litigation Europe umbrella. This stream remains the anchor event for the life sciences audience, attracting around 600 attendees, with an exceptional 45% in-house counsel ratio from leading pharmaceutical innovators, biotechs, generics and biosimilar devel…
The Pharma and Biotech Patent Litigation Conference
Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…
29th Edition Strategic Project & Portfolio Management for Pharma
Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…
29th Edition Strategic Project & Portfolio Management for Pharma
The 10th Liquid Biopsy for Precision Oncology Summit is the leading annual meeting for pharma, biotech, diagnostics, consortia, academia and patient voices to accelerate collaboration and progress in the rapidly advancing field of liquid biopsy.  Now in its 10th year, this meeting delivers unparalleled insights, data, technology updates, and strategies spanning the entire drug development pipeline - from preclinical discovery, through clinical translation, to regulatory approval, reimbursement, and commercial adoption.  If you are working in precision oncology, or need enhanced insights into your patient population, optimized diagnostic and prognostic tools, or earlier detection of disease, this meeting should be considered a staple entry in your conference calendar. Across ctDNA…
10th Liquid Biopsy for Precision Oncology Summit | February 3-5, 2026 | Free* for Biopharma
With Novartis committing $750M to ProFound Therapeutics to discover new cardiovascular candidates, and Illumina acquiring SomaLogic for $425 to expand its proteomic capabilities just this year alone, the increasing recognition of proteomics as a transformative force in drug discovery is unquestionable. Returning to Boston for its second year, the Proteomics-Based Drug Discovery Summit is the premier industry event dedicated to harnessing the full power of proteomics across drug discovery pipelines. Designed for scientific innovators like you, explore how next-generation proteomic platforms are accelerating understanding of pathology, unveiling novel drug targets, and transforming hit-to-lead development. With a special focus on optimizing proteomics instruments to balance throughput and se…
2nd Proteomic Based Drug Discovery Summit 2026
Join us at the forefront of innovation at the Marcus Evans 15th Edition R&D and Innovation Excellence Forum, where industry leaders will explore the latest strategies to optimise investments, streamline decision-making, and accelerate transformation in R&D and Innovation. Dive into practical insights on balancing portfolios, maximising ROI, and aligning innovation with market demands. This event is your gateway to understanding how to drive efficiency, foster cross-functional collaboration, and refine R&D and Innovation processes to stay ahead in an increasingly competitive landscape. Don't miss out on this opportunity to empower your R&D team with the tools and knowledge to thrive in a rapidly evolving market. Key Topics Include:  Achieving Operational Excellence in…
15th Edition R&D and Innovation Excellence Forum
The Pharma Market Research Conference East (February 4-5, 2026, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities. For more information, please go to http://pharmamarketresearchconference.com/ , call +1-212-228-7974, or email info@pharmamarketresearchconference.com

This highly interactive two-day course uses real life examples and explores proven techniques for reducing costs, usually by two-thirds, associated with implementing, and maintaining computer systems in regulated environments. It details the requirements for Part 11 and Annex 11: SOPs, software product features, infrastructure qualification, and validation. The instructor addresses the latest computer system industry standards for data security, data transfer, audit trails, electronic records and signatures, software validation, and computer system validation. Understand the specific requirements associated with local and SaaS/cloud hosting solutions. Nearly every computerized system used in laboratory, clinical, manufacturing settings and in the quality process has to be validated. Parti…

In this two day workshop conference you will learn the requirements and expectations of major health care regulators that are applicable to "virtual" companies. You will learn how to diagnose your company's needs based on which GMP and GCP-governed operations you retain and which you outsource; what the current expectations and best industry practices are for selecting, qualifying and monitoring your contractors to ensure they are meeting your requirements; and how to build a quality system framework that is not excessive for your current needs, but has the structure and integration to "grow with you" as the scope your operations change in the coming months and years. Learning Objectives: Participants in this seminar will: Understand the GMP and GCP requirements all virtual companies must…

Use coupon COMPLIANCE15 to get 15% discount on this virtual seminar This seminar bridges that gap. Designed specifically for non-statisticians, it provides a clear, practical introduction to biostatistics without overwhelming you with mathematics. You’ll learn the “why” behind the numbers, gain tools to spot meaningful findings, and avoid being misled by misused statistics. By the end of the program, you’ll be able to read statistical reports with confidence, communicate findings to colleagues and stakeholders, and make better data-driven decisions that can shape the future of clinical and biotech innovation. Why Should You Attend: In the world of clinical research and biotechnology, numbers carry weight. A single statistical finding can influence whether a project moves forward, a regulat…

Use coupon COMPLIANCE15 to get 15% discount on this virtual seminar Sterile products may be broadly classified into two main categories based on their production mode -- those that are terminally sterilized following the filling and sealing of the container and those that are aseptically sterilized, that is, filter sterilized as a bulk product, filled, and then sealed. Aseptic Processing play a critical role with large molecules that cannot be terminally sterilized. The verification of the process to produce sterile product is evaluated through the demonstration of various media fill process simulations that will vary in both numbers and size of the containers as well as the volumes filled over a defined period.  Aseptic Processing involves risk assessment on an on-going basis because…
SAE Media Group's AI in Drug Discovery 2026 takes place 9–10 March in London. Join pharma and biotech leaders to explore how AI, ML, and generative tools are transforming drug pipelines. The agenda features case studies, clinical updates, and expert panels on target ID, computational design, and scaling AI across R and D. Discover the latest breakthroughs and connect with directors and heads of informatics, molecular design, and data science.   Date and Time: On Monday March 09, 2026 at 8:30 am to Tuesday March 10, 2026 at 6:00 pm Venue details: Hilton London Kensington, 179-199 Holland Park Avenue, London, England, W11 4UL, United Kingdom
AI in Drug Discovery Conference, 9-10 March, Hilton, Kensington, London
The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment. Key Topics Include:  Transform S&OP into IBP to Connect Strategy, Finance, and Execution Cross Functional Collaboration – Key for Successful S&OP/IBP Balance Short- and Long-Term Planning to Enable Strategic Alignment Leverage AI and Data to Strengthen S&OP and IBP Foundations Drive Change Management to Advance S&OP and IBP Maturity Align Portfolio and Demand to Build a Single Planni…
S&OP and IBP for Pharma & Life Science
24-Mar-2026 - 26-Mar-2026
CMAC Open Days 2026: Join us 24–26 March 2026 as we celebrate 15 years of CMAC transforming medicines manufacturing. Discover how Industry 5.0 technologies are shaping the future of medicines manufacturing, with insights into the latest trends, tools, and strategies for creating future-ready, resilient and sustainable manufacturing processes. At the Open Days you’ll: 🤝 Network with top academics, industry leaders, and researchers 👩‍🔬 Engage in interactive sessions, lab tours, and poster presentations 💊 Learn about the latest innovations tackling real-world pharmaceutical challenges 🎟️ Registration is now open! Take advantage of early bird rates available until Monday 2 February 2026: £100 standard (rising to £125 after early bird) £80 PhD student (rising to £90 after early bird)
The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…
17th Edition Strategic Alliance Management for Pharma
The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…
17th Edition Strategic Alliance Management for Pharma
20-May-2026 - 21-May-2026
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  
EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.The 24th EuroQSAR Symposium,  entitled "Synergizing AI and Multiscale Modeling for Drug Discovery", is organised on behalf of QCMS and is chaired by Jordi Mestres (University of Girona). The symposium will focus on: Computational Design of Covalent Drugs Free Energy and Kinetics of Drug-target Binding Omics Science in Drug Discovery Artificial Intelligence and Statistical Learning in Drug Discovery QSAR and Machine Learning for DM/PK In silico/in vitro Models for Drug Safety Virtual Screening Successful Stories Next-generation Docking: Focus on Conformational Entrop…